Urol. praxi, 2011; 12(3): 170-172

Hormonal treatment in radiation therapy for locally advanced prostate cancer

MUDr.Jana Katolická, Ph.D.
Onkologicko-chirurgické oddělení, FN u sv. Anny, Brno

Hormonal therapy with radiotherapy or following radiotherapy for all patients with locally advanced prostate cancer improved overall

survival, disease-specific survival and disease-free survival.

Keywords: radiotherapy, hormonal therapy

Published: June 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Katolická J. Hormonal treatment in radiation therapy for locally advanced prostate cancer. Urol. praxi. 2011;12(3):170-172.
Download citation

References

  1. Bria E, et al. Does hormone treatment added o radiotherapy improve outcome in locally advanced prostate cancer? Cancer 2009; 115: 3446-3456. Go to original source... Go to PubMed...
  2. Bolla M, Collette L, Blank L, et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 2002; 360(9327): 103-106. Go to original source... Go to PubMed...
  3. Pilepich MV, Winter K, Lawton CA, et al. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma-long-term results of phase III RTOG 85-31. Int J Radiat Oncol Biol Phys 2005; 61(5): 1285-1290. Go to original source... Go to PubMed...
  4. Zagars GK, Johnson DE, Von Eschenbach AC, Husary DH. Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: long-term results of prospective randomized study. Int J Radiat Oncol Biol Phys 1988; 14(6): 1085-1091. Go to original source... Go to PubMed...
  5. Tyrrell CJ, Payne H, See WA, et al. Bicalutamide (Casodex) 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer Programme. Radiother Oncol 2005; 76(1): 4-10. Go to original source... Go to PubMed...
  6. Shelley MD, Kumar S, Coles B, Wilt T, Staffurth J, Mason MD. Adjuvant hormone therapy for localised and locally advanced prostate carcinoma: A systematic review and meta-analysis of randomised trials. Cancer Treatment Reviews, 2009; 35: 540-546. Go to original source... Go to PubMed...
  7. Bolla M, Collette L, Van Tienhoven G, et al. Ten-year results of long-term adjutant androgen deprivation with goserelin in patients with localy advanced prostate cancer treated with radiotherapy: a phase III EORTC Study. Int J Radiat Oncol Biol Phys, 2008; 72: S30-S31. Go to original source...
  8. D´Amico AV, Chen MH, Renshaw AA, Loffredo M, Kantoff PW. Androgen suppression and radiation vs radition alone for prostate cancer: a randomized trial JAMA. 2008; 99: 289-295. Go to original source... Go to PubMed...
  9. Denham JW, Steigler A, Lamb DS, et al. Short-term androgen deprivation nd radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial. Lancet Oncol. 2005; 6: 841-850. Go to original source... Go to PubMed...
  10. Laverdiere J, Nabid A, De Bedoya LD, et al. The efficacy and sequencing of a short course af androgen suppression on freedom from biochemical failure whe administered with radiation therapy for T2-T3 prostate cancer. J Urol. 2004; 171: 1137-1140. Go to original source... Go to PubMed...
  11. Roach M 3rd, Bae K, Speight J, et al. Short-term neoadjuvant androgen deprivation therapy and exteranl-beam rdiotherapy for locally advanced prostate cancer: long-term results of ROG 8610. J Clin Oncol. 2008; 26: 585-591. Go to original source... Go to PubMed...
  12. Bria E, Cuppone F, Giannarelli D, et al. Does Hormone Treatment Added to Radiotherapy IMprove Outcome in Locally Advanced Prostate Cancer? Cancer. 2009; 115: 3446-3456. Go to original source... Go to PubMed...
  13. D´Amico AV, enham JW, Crook J, et al. Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol. 2007; 25: 2420-2425. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.